a hybrid between family office and venture capital fund.
We have not raised money from investors which allows us to answer only to our own convictions. We invest in long term prospects where we have a value added proposition other than monetary investment alone. This structure allows us to work with our companies day and night until they succeed. We use only our own funds which forces us to be thoughtful but also reflect on our value proposition. We are nimble and fast acting. A substantial investment can be made in a matter of days if it is the right fit. Our companies find our depth and breadth of knowledge and know-how to be extremely valuable as long-term partners who help them succeed and rise to the next level.
Dr. Edward Lung
Dr. Edward Lung is an associate professor of medicine and gastroenterology at Mount Sinai School of Medicine. He specializes in advanced endoscopic techniques. Ed is the Director of Endoscopy at Mount Sinai West and Mount Sinai St. Luke’s. He also serves as the Associate Program Director of the Gastroenterology Fellowship training program. Ed has very deep experience in various medical devices and has been the healthcare investment specialist for a large European family office for the past five years. He brings with him a wealth of knowledge regarding hospital systems, infrastructure, and technology.
Areas of Expertise: Medical Devices, Hospital Administration, Healthcare Delivery, Medical Technology
Dr. Joseph Oved
Dr. Paul Low
Areas of Expertise: Healthcare Systems, Insurance, Healthcare/Medical Technology
Dr. Ronald Mizrahi
John R. Costantino is a Managing General Partner of NGN Capital LLC, a series of healthcare focused venture funds with offices in New York and Heidelberg, Germany. He is a lawyer and CPA. John was Managing Tax Partner in the New York office of Touché Ross & Co. and then President of Integrated Resources Acquisition Corporation. He was Chief Operating Officer of Conair Corporation, a large household and personal care company. He was a founding partner of a private equity fund, merchant banking group and co-founded several biotech and medical device companies.
Our Portfolio of Companies
Owlet Care is aimed at making connected smart devices for infant vital sign monitoring. Several of our partners have invested in Owlet Care prior to the formation of New World Health and we have been very pleased to continue our partnership and invest funds, resources and connections through NWH.
EPICURED is a prepared meal delivery service that focuses on celebrity-chef inspired meals for people with gluten intolerance, FODMAP restrictions and other gastrointestinal related food requirements. They have started in NYC and continue to grow now with the backing of NWH, Mount Sinai and others. NWH was proud to participate in EPICURED’s seed round investment and continue to work with them on company development.